A Study of TSRA-196 in Adults With PiZZ Alpha-1 Antitrypsin Deficiency (AATD)
Clinical trial NCT07227207 · RECRUITING
Trial details
- NCT number
- NCT07227207
- Sponsor
- Tessera Therapeutics, Inc.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-21
- Primary completion
- 2029-03-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.